ArticlePathogens (Basel, Switzerland)2023

The Therapeutic Monoclonal Antibody Bamlanivimab Does Not Enhance SARS-CoV-2 Infection by FcR-Mediated Mechanisms.

Robert W Cross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.